OBJECTIVES:

Seventeen states do not provide Medicaid coverage for neonatal male circumcision, despite American Academy of Pediatrics recommendations supporting access for families that choose it. Our study objectives were to (1) compare state-specific trends in neonatal circumcision to previously established estimates and (2) assess the impact of changes in Medicaid coverage of the procedure.

METHODS:

The State Inpatient Databases were used to determine rates of neonatal male circumcision in 4 states (CO, FL, MI, and NY) at 4 time points (2001, 2006, 2011, 2016). Neonatal circumcision was defunded by Medicaid in Florida (2003) and Colorado (2011). A multivariable logistic regression model was created to assess associations between patient and state characteristics and odds of neonatal circumcision.

RESULTS:

Overall, 54.5% of neonates underwent circumcision. States where Medicaid defunded neonatal circumcision revealed a decrease in circumcision rates in subsequent years (47.4% to 37.5% in FL; 61.9% to 52.0% in CO). Neonates with private insurance had higher odds of circumcision compared with those with public insurance (adjusted odds ratio [aOR] 2.23; 95% confidence interval [CI] 2.21–2.25). When Medicaid coverage was available, Black neonates had higher odds of circumcision compared with white neonates (aOR 1.44; 95% CI 1.42–1.46). When Medicaid coverage was not available, Black neonates had lower odds compared with white neonates (aOR 0.40; 95% CI 0.39–0.41).

CONCLUSIONS:

State-specific data reveal trends in neonatal circumcision similar to previous national estimates. Colorado and Florida revealed 20.9% and 16.0% reductions in neonatal circumcision rates, respectively, after defunding. Black neonates appeared to be disproportionately affected by changes in Medicaid coverage.

What’s Known on This Subject:

The American Academy of Pediatrics supports access to neonatal circumcision, yet 17 states do not offer Medicaid coverage for the procedure. Neonatal circumcision rates have been decreasing modestly in the United States because of factors including cost and access.

What This Study Adds:

In this study, we assess the impact of discontinuation of Medicaid funding for neonatal circumcision on rates of neonatal circumcision in different racial and/or ethnic groups. Black neonates are disproportionately impacted by these changes in Medicaid policy when compared with other racial and/or ethnic groups.

Male circumcision is a commonly performed procedure in the United States, with an estimated 80.5% of male patients in the United States undergoing circumcision.1  The procedure is predominantly performed in the neonatal period; ∼56% of boys born in the United States undergo neonatal circumcision.2  The decision to perform neonatal circumcision is made by parents on the basis of multiple factors, including perceived benefits and cultural, social, and religious considerations.36  As a result, there is a wide range of circumcision rates across the United States, with highest circumcision rates seen among white non-Hispanic boys, those with private health insurance, and boys in families living above the poverty line.7  There is strong evidence of the medical benefit of circumcision, including reduction in rates of HIV,810  reduction in rates of male to female transmission of HIV,11  reduced prevalence of human papillomavirus (HPV),12  increased clearance of high-risk strains of HPV,13  reduced risk of penile cancer,14,15  and reduced risk of febrile urinary tract infections during infancy.16  Many of the medical benefits of circumcision are experienced in late adolescence and adulthood; however, delaying the procedure past the neonatal period is associated with increased costs, surgical risks, and complications.17,18 

Given the medical benefits of the circumcision and the low initial cost of performing it in the neonatal period, a 2012 American Academy of Pediatrics task force on male circumcision concluded that the “benefits of newborn male circumcision outweigh the risks [and that] the benefits of newborn male circumcision justify access to this procedure for families who choose it.”19  Most private insurers in the United States provide coverage for neonatal circumcision.20  However, over the past few years, some states have discontinued publicly funded (Medicaid, Children’s Health Insurance Program) (hereinafter “Medicaid”) coverage of neonatal circumcision. As of 2014, 18 states do not currently offer any Medicaid coverage for neonatal circumcision,21  and only Colorado has reinstated coverage since that time.22  Neonatal circumcision rates have decreased modestly over the last several decades in the United States.1,7  Although changing parental preferences and demographic shifts likely contribute to this trend, lack of Medicaid coverage has been identified as a pertinent factor.23,24  Studies assessing national trends in neonatal circumcision have revealed that access to the procedure may be contributing to emerging disparities.2  Although in previous studies, authors have described regional and demographic trends in neonatal circumcision over time, no detailed analyses of the impact of changes in Medicaid coverage are available. Our aim for this study was to assess the impact of state-level changes in Medicaid coverage of neonatal male circumcision on the frequency and demographic characteristics of neonates undergoing the procedure. We hypothesized that neonates of lower socioeconomic status would have lower rates of neonatal circumcision and that neonatal circumcision rates would decrease disproportionately in states that discontinued Medicaid coverage for the procedure during the study time period.

A retrospective cohort study of neonates born at hospitals in 4 US states in the years 2001, 2006, 2011, and 2016 was conducted. State-specific neonatal circumcision rates were calculated for each study year and compared to previously established national estimates. The impact of state-level changes in Medicaid coverage for neonatal circumcision was evaluated. The study was deemed exempt (analysis of de-identified, previously collected data) by the Ann & Robert H. Lurie Children’s Hospital of Chicago Institutional Review Board.

The State Inpatient Databases (SID) are a subset of the Healthcare Cost and Utilization Project, sponsored by the Agency for Healthcare Research and Quality. Each individual database contains data from an estimated 97% of inpatient hospitalizations for a given state and year. Study states were selected to optimize diversity in region of the United States, population demographics, and population density. Medicaid funding for neonatal circumcision during the study time period (continuous versus discontinued) was also taken into consideration for selection of study states. The final study cohort was constructed by using combined data from 4 states (CO, FL, NY, and MI) at 4 time points (2001, 2006, 2011, and 2016). Neonatal circumcision was covered by Medicaid in all 4 states in 2001. Medicaid funding for neonatal circumcision was discontinued in Florida (2003) and Colorado (2011) during the study period (Table 1).

TABLE 1

Medicaid Coverage for Neonatal Circumcision Stratified by State and Year

StateRegionCoverage
2001200620112016
New York East Yes Yes Yes Yes 
Florida South Yes No No No 
Michigan Midwest Yes Yes Yes Yes 
Colorado West Yes Yes Yes No 
StateRegionCoverage
2001200620112016
New York East Yes Yes Yes Yes 
Florida South Yes No No No 
Michigan Midwest Yes Yes Yes Yes 
Colorado West Yes Yes Yes No 

Male neonates who were discharged from an inpatient stay were included in the cohort. Neonates were identified on the basis of admission type (neonatal). Neonates with coagulopathies, genitourinary anomalies, or prematurity were identified by International Classification of Diseases, Ninth Revision and International Classification of Diseases, 10th Revision diagnosis codes and excluded. The primary study outcome was inpatient neonatal circumcision, as determined by International Classification of Diseases, Ninth Revision and International Classification of Diseases, 10th Revision procedure coding. Because the SID only include inpatient events, outpatient circumcision and related encounters are not observed in the SID.

Descriptive statistics were used to characterize the study population. Logistic regression models were created to assess the association between patient characteristics, state characteristics, and the predicted odds of neonatal circumcision. Variables in the model included year, state, race and/or ethnicity, insurance status, and Medicaid coverage of neonatal circumcision. Univariable and multivariable analyses were performed. Neonates in the collapsed “other” race category included the following groups: Asian or Pacific Islander, American Indian, and other. None of these individual racial groups accounted for >8% of the population at any given time. A difference-in-differences estimation was used to assess the effect of discontinuation of Medicaid coverage for neonatal circumcision on the odds of neonatal circumcision in the population insured by Medicaid. An indicator variable for discontinuation of Medicaid coverage for neonatal circumcision (defined as the time after which circumcision was not covered by Medicaid) and an indicator variable for being covered by Medicaid were created. An interaction term between the 2 indicator variables was included in a logistic regression model (controlling for state, race and/or ethnicity, and year) to assess for the impact of policy change in the publicly insured population. A separate interaction term was included in the multivariable model to assess whether the effect of discontinuation of Medicaid coverage for neonatal circumcision on the odds of neonatal circumcision was different for different racial and/or ethnic groups. All statistical analyses were performed by using Stata 15.1 statistical software (Stata Corp, College Station, TX), and a P value of <.05 was considered statistically significant.

A total of 1 149 576 male neonates were included in the study (Table 2). The cohort included 278 000 to 294 000 neonates per study year. The number of eligible neonates varied widely by state, with Florida and New York accounting for three-quarters of the cohort (36.8% and 40.0%, respectively) and Colorado accounting for only 8.4%. The cohort was 52.8% white, 45.3% covered by Medicaid, and 47.6% covered by private insurance over all study years combined.

TABLE 2

Demographic Characteristics of Study Population

n%
Circumcision performed   
 Yes 626 755 54.5 
 No 522 821 45.5 
Year   
 2001 278 117 24.2 
 2006 294 608 25.6 
 2011 285 579 24.8 
 2016 291 272 25.3 
Race and/or ethnicity   
 White 606 831 52.8 
 Black 202 321 17.6 
 Hispanic 195 647 17.0 
 Other 144 777 12.6 
State   
 New York 459 824 40.0 
 Florida 423 235 36.8 
 Michigan 170 302 14.8 
 Colorado 96 215 8.4 
Insurance   
 Public 520 326 45.3 
 Private 547 619 47.6 
 Other 81 631 7.1 
n%
Circumcision performed   
 Yes 626 755 54.5 
 No 522 821 45.5 
Year   
 2001 278 117 24.2 
 2006 294 608 25.6 
 2011 285 579 24.8 
 2016 291 272 25.3 
Race and/or ethnicity   
 White 606 831 52.8 
 Black 202 321 17.6 
 Hispanic 195 647 17.0 
 Other 144 777 12.6 
State   
 New York 459 824 40.0 
 Florida 423 235 36.8 
 Michigan 170 302 14.8 
 Colorado 96 215 8.4 
Insurance   
 Public 520 326 45.3 
 Private 547 619 47.6 
 Other 81 631 7.1 

Overall, 54.5% of neonates underwent neonatal circumcision. Neonatal circumcision rates were highest in Michigan (84.5%) and lowest in Florida (37.8%). In states where Medicaid coverage for neonatal circumcision was discontinued during the study period, there was a decrease in circumcision rates in the years after discontinuation (from 47.4% to 37.5% in FL [2001–2006] and from 61.9% to 52.0% in CO [2011–2016]; Fig 1). In the 2 states where Medicaid coverage for neonatal circumcision was discontinued, the largest changes in neonatal circumcision rates were seen among neonates covered by Medicaid in the years after discontinuation of Medicaid coverage for the procedure (from 34.9% to 19.6% in FL [2001–2006] and from 48.1% to 36.7% in CO [2011–2016]; Fig 2).

FIGURE 1

Rate of neonatal circumcision stratified by state.

FIGURE 1

Rate of neonatal circumcision stratified by state.

Close modal
FIGURE 2

Rate of neonatal circumcision stratified by state and insurance coverage. A, Covered by private insurance. B, Covered by Medicaid.

FIGURE 2

Rate of neonatal circumcision stratified by state and insurance coverage. A, Covered by private insurance. B, Covered by Medicaid.

Close modal

Unadjusted analyses revealed higher odds of neonatal circumcision among neonates from Michigan compared with Colorado, among neonates with private insurance compared with public insurance, and among non-Hispanic white neonates compared with those of all other racial and/or ethnic groups (Table 3). Further exploration of interaction terms and difference-in-differences analyses indicated that associations between race and/or ethnicity and insurance status and odds of neonatal circumcision also depended Medicaid coverage for the procedure. The difference-in-differences estimation revealed that the discontinuation of Medicaid coverage for neonatal circumcision had a statistically significant negative effect on the odds of neonatal circumcision in the population covered by Medicaid versus those covered by private insurance (adjusted odds ratio [aOR] 0.43; 95% confidence interval [CI] 0.43–0.44). In the multivariable regression model with interaction terms, neonates covered by private insurance had higher odds of neonatal circumcision than neonates covered by Medicaid (aOR 2.23; 95% CI 2.21–2.25) when controlling for other factors (Table 4). The interaction term revealed an association between race and/or ethnicity and Medicaid coverage of neonatal circumcision, suggesting that the effect of discontinuation of Medicaid coverage for neonatal circumcision on the odds of neonatal circumcision varied by racial and/or ethnic group. When Medicaid coverage for the procedure was available, Black neonates had significantly higher odds of neonatal circumcision than white neonates (aOR 1.44; 95% CI 1.42–1.46). When Medicaid coverage for neonatal circumcision was not available, Black neonates had significantly lower odds of neonatal circumcision than white neonates (aOR 0.40; 95% CI 0.39–0.41). In contrast, Medicaid funding for neonatal circumcision was not associated with substantive differences in the comparative rates of neonatal circumcision for Hispanic and non-Hispanic other race neonates compared with non-Hispanic white neonates (Table 4).

TABLE 3

Predicted Odds of Neonatal Circumcision: Univariate Regression Model

Main EffectsOdds Ratio95% CI
State   
 Colorado Reference — 
 Florida 0.41 0.40–0.41 
 Michigan 3.65 3.58–3.71 
 New York 0.91 0.90–0.92 
Insurance status   
 Public Reference — 
 Private 2.64 2.62–2.66 
 Other 1.07 1.05–1.09 
Race and/or ethnicity   
 White Reference — 
 Black 0.73 0.72–0.73 
 Hispanic 0.21 0.20–0.21 
 Other 0.44 0.43–0.44 
Main EffectsOdds Ratio95% CI
State   
 Colorado Reference — 
 Florida 0.41 0.40–0.41 
 Michigan 3.65 3.58–3.71 
 New York 0.91 0.90–0.92 
Insurance status   
 Public Reference — 
 Private 2.64 2.62–2.66 
 Other 1.07 1.05–1.09 
Race and/or ethnicity   
 White Reference — 
 Black 0.73 0.72–0.73 
 Hispanic 0.21 0.20–0.21 
 Other 0.44 0.43–0.44 

Adjusted for year. —, not applicable.

TABLE 4

Predicted Odds of Neonatal Circumcision: Multivariate Regression Model

Main EffectsOdds Ratio95% CI
 State   
  Colorado Reference — 
  Florida 0.52 0.51–0.53 
  Michigan 2.72 2.67–2.77 
  New York 0.87 0.85–0.88 
 Insurance status   
  Public Reference — 
  Private 2.23 2.21–2.25 
  Other 1.24 1.22–1.26 
Interaction effects   
 Race and/or ethnicity funded   
  White Reference — 
  Black 1.44 1.42–1.46 
  Hispanic 0.31 0.30–0.31 
  Other 0.47 0.47–0.48 
 Race and/or ethnicity defunded   
  White Reference — 
  Black 0.40 0.39–0.41 
  Hispanic 0.34 0.33–0.35 
  Other 0.44 0.43–0.44 
Main EffectsOdds Ratio95% CI
 State   
  Colorado Reference — 
  Florida 0.52 0.51–0.53 
  Michigan 2.72 2.67–2.77 
  New York 0.87 0.85–0.88 
 Insurance status   
  Public Reference — 
  Private 2.23 2.21–2.25 
  Other 1.24 1.22–1.26 
Interaction effects   
 Race and/or ethnicity funded   
  White Reference — 
  Black 1.44 1.42–1.46 
  Hispanic 0.31 0.30–0.31 
  Other 0.47 0.47–0.48 
 Race and/or ethnicity defunded   
  White Reference — 
  Black 0.40 0.39–0.41 
  Hispanic 0.34 0.33–0.35 
  Other 0.44 0.43–0.44 

Adjusted for year. —, not applicable.

Neonatal circumcision rates in the current study closely mirror previously established regional and national estimates,2,7  indicating differences by US region and a modest overall decline in neonatal circumcision rates over time. In Colorado and Florida, Medicaid coverage for neonatal circumcision was discontinued during the study period, and rates declined more significantly in those states versus with Michigan and New York, where Medicaid coverage for the procedure was continuous. A decrease in neonatal circumcisions among neonates covered by Medicaid appears to be contributing to the overall decline in rates of neonatal circumcision, and non-Hispanic Black neonates were the group most significantly impacted by discontinuation of Medicaid coverage for neonatal circumcision.

Researchers of previous studies have sought to estimate rates of neonatal circumcision at state and national levels using large databases. However, most studies to date rely on sampled data intended to be used as a national or regional sample, limiting the ability to evaluate state-level changes in access to the procedure. Additionally, given the sampled nature of the data, doubts have been raised about the accuracy of previous estimates. In this study, we use population-level data to investigate rates of circumcision at the state level, allowing for conclusions about state-level changes in Medicaid coverage for neonatal circumcision to be drawn. The rates of circumcision from this study trend closely with previously established regional estimates,2,7  validating previous analyses.

Several organizations, including the American Academy of Pediatrics, have determined that the benefits of neonatal circumcision are sufficient to justify access to the procedure for families who choose it. Although many factors may influence whether families pursue neonatal circumcision, affordability of the procedure has been identified as a main factor in the decision-making process. By discontinuing Medicaid coverage for the procedure, states are ultimately influencing the decision-making process in a manner that is inconsistent with current evidence-based clinical guidance. Given the demographic distribution of the population covered by Medicaid, certain groups are disproportionately affected. A lifetime cost simulation model published by Kacker et al25  in 2012 estimated a high likelihood of increased Medicaid expenditures if rates of male circumcision in the United States were to decrease, suggesting that the long-term financial benefits of the procedure far outweigh the initial cost. This financial benefit was predominantly linked to higher rates of urinary tract and sexually transmitted infections in a population with lower rates of male circumcision. Although this does not justify recommending that all boys undergo the procedure, it does support the position that families who choose for their child to undergo the procedure should have access to circumcision in the neonatal period. In 2013, Introcaso et al1  suggested that low-income populations, including those covered by Medicaid, stand to gain the most from the medical benefits of the procedure. This raises concern that discontinuation of Medicaid coverage for neonatal circumcision may be a key contributor to health disparities, such as transmission of HIV or prevalence of HPV. Combined with the findings in our study, one can conclude that discontinuing coverage of neonatal circumcision under Medicaid is creating access barriers for the population who will benefit the most from the procedure.

A second potential impact of changes in Medicaid coverage of neonatal circumcision not directly addressed in this study is the potential for increased incidence of delayed elective circumcision among the population covered under Medicaid. In 2013, Gutwein et al23  published an analysis of outpatient data in Florida, comparing boys covered by Medicaid with those covered by private insurance, and demonstrated a significant sixfold increase in nonneonatal (delayed) circumcision rates after discontinuation of Medicaid coverage for neonatal circumcision in the state. A racial difference was also seen, with a 77.3% increase in outpatient circumcision among Black boys compared with a 28.7% increase among white boys in the same time period.23  The concern is that removing coverage for neonatal circumcision under Medicaid may decrease the rates of the safer, less costly procedure in exchange for a concurrent increase in the more expensive one, which will expose boys to higher risk and the increased potential for complications.

The Colorado Department of Health Care Policy and Financing reinstated funding for neonatal circumcision in September 2017, 6 years after initial discontinuation of Medicaid funding for neonatal circumcision.22  To the best of the authors’ knowledge, there is no publicly available statement justifying the decision to reinstate coverage for the procedure. Follow-up studies on how reinstatement of neonatal circumcision coverage affects circumcision rates within a population could provide valuable information to support the development of future policies.

This study is limited by use of multiple individual databases from relatively few states and years to assess the impact of Medicaid coverage changes. In particular, we were unable to include more recent data because 2016 was the most recent year available for all states. Our 4-state approach also limits generalizability to all states, or the United States as a whole, given the many factors that impact decision-making regarding neonatal circumcision. However, we note that the inclusion of 3 of the 10 most populous states with a wide range of demographics is likely illustrative of broad national trends and echoes rates of neonatal circumcision reported in other studies. Additionally, the differences in variable availability between databases limited inclusion of some variables of interest in the final analysis. Finally, use of population-level databases does not allow for a thorough assessment of all factors that contribute to an individual family’s decision to pursue neonatal circumcision. However, the use of a difference-in-differences analysis can mitigate this problem of unobserved data by assuming that such factors are unlikely to change as substantially over time within each state as the major policy change in Medicaid that was observed.

Within the context of its limitations, this population-level study provides essential insight about neonatal circumcision rates in 4 US states with different demographic profiles. The study design allowed for a detailed analysis of state-level changes in Medicaid coverage of neonatal circumcision. The impact of the change is apparent in the study, and follow-up studies are underway to assess the long-term impact on individual boys and society. One such potential impact could be the increase in rates of elective operative outpatient circumcision in the same population, a procedure with higher complication rates and cost when compared to neonatal circumcision. Such unintended consequences of Medicaid policy may have long-standing health implications that merit reconsideration of the policy as a way to safeguard lifelong health while also reducing the cost burden for Medicaid. Although this study expands our understanding of how policy affects neonatal circumcision rates, many questions remain. Further studies on how reinstating Medicaid coverage for neonatal circumcision affects rates of the procedure and how demographic shifts are expected to affect rates of neonatal circumcision would help guide future policy decisions.

State-specific data reveal trends in neonatal circumcision rates and racial distributions that mirror previous national and regional estimates. Colorado and Florida revealed reductions in neonatal circumcision in the years after defunding, which appear unlikely to be due to secular trends alone. Black neonates appear to be disproportionately affected by changes in Medicaid coverage of neonatal circumcision.

Mr Zambrano Navia conceptualized and designed the study, analyzed and interpreted the data, drafted the initial manuscript, and reviewed and revised the manuscript; Drs Jacobson and Johnson and Ms Rosoklija conceptualized and designed the study and critically reviewed and revised the manuscript; Dr Balmert contributed to the analysis and interpretation of data and results and critically reviewed and revised the manuscript; Drs Davis and Holl contributed to the analysis of results and critically reviewed and revised the manuscript; and all authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

FUNDING: No external funding.

aOR

adjusted odds ratio

CI

confidence interval

HPV

human papillomavirus

SID

State Inpatient Databases

1
Introcaso
CE
,
Xu
F
,
Kilmarx
PH
,
Zaidi
A
,
Markowitz
LE
.
Prevalence of circumcision among men and boys aged 14 to 59 years in the United States, National Health and Nutrition Examination Surveys 2005–2010
.
Sex Transm Dis
.
2013
;
40
(
7
):
521
525
2
Leibowitz
AA
,
Desmond
K
,
Belin
T
.
Determinants and policy implications of male circumcision in the United States
.
Am J Public Health
.
2009
;
99
(
1
):
138
145
3
Bisono
GM
,
Simmons
L
,
Volk
RJ
,
Meyer
D
,
Quinn
TC
,
Rosenthal
SL
.
Attitudes and decision making about neonatal male circumcision in a Hispanic population in New York City
.
Clin Pediatr (Phila)
.
2012
;
51
(
10
):
956
963
4
Castro
JG
,
Jones
DL
,
López
MR
,
Deeb
K
,
Barradas
I
,
Weiss
SM
.
Acceptability of neonatal circumcision by Hispanics in southern Florida
.
Int J STD AIDS
.
2010
;
21
(
8
):
591
594
5
Jia
L
,
Hawley
SR
,
Paschal
AM
,
Fredrickson
DD
,
St Romain
TL
,
Cherven
PL
.
Immigrants vs. non-immigrants: attitudes toward and practices of non-therapeutic male circumcision in the United States of America
.
J Cult Divers
.
2009
;
16
(
3
):
92
98
6
Corduk
N
,
Unlu
G
,
Sarioglu-Buke
A
,
Buber
A
,
Savran
B
,
Zencir
M
.
Knowledge, attitude and behaviour of boys and parents about circumcision
.
Acta Paediatr
.
2013
;
102
(
4
):
e169
e173
7
Warner
L
,
Cox
S
,
Whiteman
M
, et al
.
Impact of health insurance type on trends in newborn circumcision, United States, 2000 to 2010
.
Am J Public Health
.
2015
;
105
(
9
):
1943
1949
8
Gray
RH
,
Kiwanuka
N
,
Quinn
TC
, et al.;
Rakai Project Team
.
Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda
.
AIDS
.
2000
;
14
(
15
):
2371
2381
9
Bailey
RC
,
Moses
S
,
Parker
CB
, et al
.
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial
.
Lancet
.
2007
;
369
(
9562
):
643
656
10
Auvert
B
,
Taljaard
D
,
Lagarde
E
,
Sobngwi-Tambekou
J
,
Sitta
R
,
Puren
A
.
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial
.
PLoS Med
.
2005
;
2
(
11
):
e298
11
Gray
RH
,
Kigozi
G
,
Serwadda
D
, et al
.
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial
.
Lancet
.
2007
;
369
(
9562
):
657
666
12
Nielson
CM
,
Schiaffino
MK
,
Dunne
EF
,
Salemi
JL
,
Giuliano
AR
.
Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners
.
J Infect Dis
.
2009
;
199
(
1
):
7
13
13
Lu
B
,
Wu
Y
,
Nielson
CM
, et al
.
Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study
.
J Infect Dis
.
2009
;
199
(
3
):
362
371
14
Larke
NL
,
Thomas
SL
,
dos Santos Silva
I
,
Weiss
HA
.
Male circumcision and penile cancer: a systematic review and meta-analysis
.
Cancer Causes Control
.
2011
;
22
(
8
):
1097
1110
15
Schoen
EJ
,
Oehrli
M
,
Colby
C
,
Machin
G
.
The highly protective effect of newborn circumcision against invasive penile cancer
.
Pediatrics
.
2000
;
105
(
3
).
16
Eisenberg
ML
,
Galusha
D
,
Kennedy
WA
,
Cullen
MR
.
The relationship between neonatal circumcision, urinary tract infection, and health
.
World J Mens Health
.
2018
;
36
(
3
):
176
182
17
Wiswell
TE
,
Tencer
HL
,
Welch
CA
,
Chamberlain
JL
.
Circumcision in children beyond the neonatal period
.
Pediatrics
.
1993
;
92
(
6
):
791
793
18
Hart-Cooper
GD
,
Tao
G
,
Stock
JA
,
Hoover
KW
.
Circumcision of privately insured males aged 0 to 18 years in the United States
.
Pediatrics
.
2014
;
134
(
5
):
950
956
19
American Academy of Pediatrics Task Force on Circumcision
.
Male circumcision
.
Pediatrics
.
2012
;
130
(
3
).
20
Clark
SJ
,
Kilmarx
PH
,
Kretsinger
K
.
Coverage of newborn and adult male circumcision varies among public and private US payers despite health benefits
.
Health Aff (Millwood)
.
2011
;
30
(
12
):
2355
2361
21
Morris
BJ
,
Bailis
SA
,
Wiswell
TE
.
Circumcision rates in the United States: rising or falling? What effect might the new affirmative pediatric policy statement have?
Mayo Clin Proc
.
2014
;
89
(
5
):
677
686
22
Colorado Department of Health Care Policy and Financing
.
Provider Bulletin
.
Denver, CO
:
Colorado Department of Health Care Policy and Financing
;
2017
:
12
23
Gutwein
LG
,
Alvarez
JF
,
Gutwein
JL
,
Kays
DW
,
Islam
S
.
Allocation of healthcare dollars: analysis of nonneonatal circumcisions in Florida
.
Am Surg
.
2013
;
79
(
9
):
865
869
24
Cheng
D
,
Hurt
L
,
Horon
IL
.
Neonatal circumcision in Maryland: a comparison of hospital discharge and maternal postpartum survey data
.
J Pediatr Urol
.
2008
;
4
(
6
):
448
451
25
Kacker
S
,
Frick
KD
,
Gaydos
CA
,
Tobian
AA
.
Costs and effectiveness of neonatal male circumcision
.
Arch Pediatr Adolesc Med
.
2012
;
166
(
10
):
910
918

Competing Interests

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.